Literature DB >> 1681824

Nigrostriatal and mesolimbic dopaminergic activities were modified throughout the ovarian cycle of female rats.

J J Fernández-Ruiz1, M L Hernández, R de Miguel, J A Ramos.   

Abstract

In this work, we have studied the changes in the functional state of nigrostriatal (NSDA) and mesolimbic (MLDA) dopaminergic neurons during the estrous cycle of the female rat. The activity of tyrosine hydroxylase (TH), the turnover rate (Kt) after inhibition of dopamine (DA) synthesis and the ratio between the contents of this amine and its metabolite, L-3,4 dihydroxyphenylacetic acid (DOPAC), were used as indices of neuronal activity. The neuronal activity of NSDA neurons rose during estrous and declined during proestrous, as reflected by the values of Kt and DOPAC/DA ratio measured during both phases. Interestingly, the course of variations in striatal TH activity was similar, although retarded in relation to the changes in neuronal activity. Thus, TH activity was high during diestrous, whereas it was low during estrous. The activity of MLDA neurons was reduced during proestrous. This can be concluded from the decreased Kt and DOPAC/DA ratio measured in this phase and it was accompanied by a low TH activity. Thereupon, both Kt and TH activity increased during estrous. These results indicate the existence of physiological changes in the functional state of both dopaminergic systems during the ovarian cycle, which are partially different for each neuronal pathway. This supports the existence of a specific regulation, and not indiscriminate effects, by the hormones involved in this cycle, mainly estradiol and progesterone.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1681824     DOI: 10.1007/bf01244947

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  30 in total

Review 1.  Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation.

Authors:  R E Zigmond; M A Schwarzschild; A R Rittenhouse
Journal:  Annu Rev Neurosci       Date:  1989       Impact factor: 12.449

2.  Effect of chronic estradiol treatment on dopamine concentrations in discrete brain nuclei of hypophysectomized female rats.

Authors:  T Di Paolo; A Dupont; M Daigle
Journal:  Neurosci Lett       Date:  1982-10-23       Impact factor: 3.046

3.  Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid.

Authors:  R H Roth; L C Murrin; J R Walters
Journal:  Eur J Pharmacol       Date:  1976-03       Impact factor: 4.432

4.  Progestin receptors in rat brain: distribution and properties of cytoplasmic progestin-binding sites.

Authors:  N J MacLusky; B S McEwen
Journal:  Endocrinology       Date:  1980-01       Impact factor: 4.736

Review 5.  Dopamine-containing neurons in the mammalian central nervous system: electrophysiology and pharmacology.

Authors:  L A Chiodo
Journal:  Neurosci Biobehav Rev       Date:  1988       Impact factor: 8.989

6.  Highly sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography.

Authors:  T Nagatsu; K Oka; T Kato
Journal:  J Chromatogr       Date:  1979-07-21

7.  Elevation of striatal dopamine receptors by estrogen: dose and time studies.

Authors:  R E Hruska
Journal:  J Neurochem       Date:  1986-12       Impact factor: 5.372

8.  Presence of tyrosine-hydroxylase activity in anterior pituitary adenomas and ectopic anterior pituitaries in male rats.

Authors:  J J Fernandez-Ruiz; A I Esquifino; R W Steger; A G Amador; A Bartke
Journal:  Brain Res       Date:  1987-09-22       Impact factor: 3.252

9.  Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain.

Authors:  J Glowinski; L L Iversen
Journal:  J Neurochem       Date:  1966-08       Impact factor: 5.372

10.  17 beta-Estradiol at a physiological dose acutely increases dopamine turnover in rat brain.

Authors:  T Di Paolo; C Rouillard; P Bédard
Journal:  Eur J Pharmacol       Date:  1985-11-05       Impact factor: 4.432

View more
  7 in total

Review 1.  Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies.

Authors:  Dean Dluzen; Martin Horstink
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

2.  Task-load-dependent activation of dopaminergic midbrain areas in the absence of reward.

Authors:  Carsten N Boehler; Jens-Max Hopf; Ruth M Krebs; Christian M Stoppel; Mircea A Schoenfeld; Hans-Jochen Heinze; Toemme Noesselt
Journal:  J Neurosci       Date:  2011-03-30       Impact factor: 6.167

3.  Feminized behavior and brain gene expression in a novel mouse model of Klinefelter Syndrome.

Authors:  Tuck C Ngun; Negar M Ghahramani; Michelle M Creek; Shayna M Williams-Burris; Hayk Barseghyan; Yuichiro Itoh; Francisco J Sánchez; Rebecca McClusky; Janet S Sinsheimer; Arthur P Arnold; Eric Vilain
Journal:  Arch Sex Behav       Date:  2014-06-13

4.  Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory.

Authors:  C Leranth; R H Roth; J D Elsworth; F Naftolin; T L Horvath; D E Redmond
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

5.  Effect of different doses of estrogen on the nigrostriatal dopaminergic system in two 6-hydroxydopamine-induced lesion models of Parkinson's disease.

Authors:  Marcela Ferreira Cordellini; Giovana Piazzetta; Karin Cristine Pinto; Ana Márcia Delattre; Francesca Matheussi; Ruither O G Carolino; Raphael Escorsim Szawka; Janete A Anselmo-Franci; Anete Curte Ferraz
Journal:  Neurochem Res       Date:  2011-02-24       Impact factor: 3.996

6.  Plasma progesterone levels and cocaine-seeking in freely cycling female rats across the estrous cycle.

Authors:  Matthew W Feltenstein; Ronald E See
Journal:  Drug Alcohol Depend       Date:  2007-01-19       Impact factor: 4.492

7.  The effects of perinatal testosterone exposure on the DNA methylome of the mouse brain are late-emerging.

Authors:  Negar M Ghahramani; Tuck C Ngun; Pao-Yang Chen; Yuan Tian; Sangitha Krishnan; Stephanie Muir; Liudmilla Rubbi; Arthur P Arnold; Geert J de Vries; Nancy G Forger; Matteo Pellegrini; Eric Vilain
Journal:  Biol Sex Differ       Date:  2014-06-13       Impact factor: 5.027

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.